Philippines unbowed by US trade threat
This article was originally published in Scrip
The foreign research-based pharmaceutical industry has come under attack by a prominent Philippine senator for pushing to have the country included on a US trade black list. Senator Mar Roxas charged that complaints over new intellectual property rules enshrined in the Universally Accessible Cheaper and Quality Medicines Act passed last year were designed to derail the legislation.
You may also be interested in...
While it has raised the full-year profit outlook, Takeda came in under analysts' consensus for some of its fiscal first-half figures, pointing to a growing forex impact.
Product review report reveals multiple delays and missteps on route to market, holding valuable lessons for other gene therapy developers but also evidencing an ultimately welcoming environment.
Join us for a quick audio roundup of major developments in the international biopharma industry over the past week, as covered by Scrip's global team.